IICS4all 2027 supports multinational research teams conducting randomized trials of existing interventions or repurposed medicines to improve clinical practice and healthcare in four disease areas.
Innovative healthcare interventions for non-communicable diseases supports research consortia testing treatments in early-stage clinical trials to improve management of cardiovascular, metabolic, lung and kidney diseases.
Investigator Initiated Studies (IIS) supports scientists and clinical researchers pursuing independent clinical, observational, and outcomes research to explore questions or develop new treatment concepts.
Investigator Initiated Studies (IIS) supports investigators conducting clinical studies of Genentech medicines to deepen understanding of treatments, improve patient care and generate disease-related research.
Clinical Research supports clinicians and researchers conducting non-commercial human and veterinary studies to generate new knowledge that improves clinical practice, diagnostics, and treatment.
Clinical Research Investigator-Initiated Awards support investigators conducting clinical studies of Crohn’s disease and ulcerative colitis to improve patient care and change clinical practice.